Cargando…
Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir
Hepatitis C-induced cholestatic hepatitis is a well-known fatal complication of postorthotropic liver transplantation and prolonged immunosuppression. Recent studies on direct-acting antiviral agents have shown promising results in terms of morbidity and mortality of this condition in postorthotropi...
Autores principales: | Nassar, Amin H., Abdul-Jawad, Baraa M., Barnes, David S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Gastroenterology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5772065/ https://www.ncbi.nlm.nih.gov/pubmed/29392153 http://dx.doi.org/10.14309/crj.2018.6 |
Ejemplares similares
-
Cholestatic hepatitis due to Salmonella typhi
por: Albayrak, Ayse, et al.
Publicado: (2011) -
Patient-reported outcomes in individuals with hepatitis C virus infection treated with elbasvir/grazoprevir
por: Ng, Xinyi, et al.
Publicado: (2018) -
Elbasvir/Grazoprevir, an Alternative in Antiviral Hepatitis C Therapy in Patients under Amiodarone Treatment
por: Weiss, Lina, et al.
Publicado: (2018) -
Azithromycin-induced cholestatic hepatitis
por: Koffas, Apostolos, et al.
Publicado: (2017) -
Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis C
por: Bell, Allison M., et al.
Publicado: (2016)